A Microsimulation Model to Determine the Cost|Effectiveness of ...

A Microsimulation Model to Determine the Cost-Effectiveness of ...

A microsimulation model for CD was built to simulate biomarker (fecal calprotectin) vs endoscopy-based monitoring in a treat-to-target fashion.

Microsimulation Model to Determine the Cost-Effectiveness of Treat ...

The combination symptom and biomarker-based monitoring resulted in the highest QALY estimate. However, symptom-based monitoring is the most cost-effective ...

Microsimulation Model to Determine the Cost-Effectiveness of Treat ...

Cost-Effectiveness Model ... The microsimulation model incorporated costs of treatment, monitoring (biomarkers or endoscopy), and complications, in addition to ...

A Microsimulation Model to Determine the Cost-Effectiveness

A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease · Abstract · INTRODUCTION · METHODS · RESULTS.

Microsimulation Model to Determine the Cost-Effectiveness of Treat ...

Transition probabilities, costs, and quality-adjusted life year (QALY) estimates were derived from published estimates. The microsimulation model tracked an ...

Microsimulation Model to Determine the Cost-Effectiveness of Treat ...

METHODS: We used a microsimulation model to identify the most cost effective treat to target monitoring strategy for patients with UC staring therapy with ...

A Microsimulation Model to Determine the Cost-Effectiveness of ...

A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease. Citation: Dulai PS, Jairath V, Narula N, ...

Microsimulation Model for Evaluating the Cost-Effectiveness of ...

We created a Markov microsimulation health state transition model of BAP1 germline carriers to predict if active surveillance for the four main tumors ...

Microsimulation Model to Determine the Cost-Effectiveness of Treat ...

The microsimulation model tracked an individual patient's disease course and treatment exposures to modify downstream treatment effectiveness, ...

A New Type 2 Diabetes Microsimulation Model to Estimate Long ...

Type 2 diabetes simulation models that project long-term health effects, costs, and cost-effectiveness of interventions can help policy makers ...

Microsimulation model for the health economic evaluation of ...

... cost-effective indicating the need for disinvestment in these medications.34The second focus will be to identify the most cost-effective osteoporosis ...

Microsimulation Model for Health Economic Evaluation of Public ...

... a microsimulation cardiovascular disease policy model (CVD-Predict) to estimate cardiometabolic end points, quality-adjusted life-years, and ...

Microsimulation model of the cost-effectiveness of anifrolumab ...

Our model captures direct SLE-related medical costs from the Dubai Health Authority. Sensitivity analyses were conducted to assess model uncertainty. Results.

Sensitivity and Threshold Analyses Using a Microsimulation Model

This allowed us to measure whether the addition of CAD technology is cost-effective when added to screening colonoscopy, particularly if CAD ...

A microsimulation model to assess the economic impact of ...

The overall budget impact of anti-PD-1 therapies 3 years after their introduction into routine use would amount to €373.1 million per year for a target ...

A Microsimulation Model to Determine the Cost-Effectiveness of ...

A microsimulation model for CD was built to simulate biomarker (fecal calprotectin) vs endoscopy-based monitoring in a treat-to-target fashion. Published ...

Microsimulation model of the cost-effectiveness of anifrolumab ...

A microsimulation model was used to assess the cost-effectiveness of anifrolumab against belimumab (IV/SC) as an add-on therapy to SoC in a ...

A New Type 2 Diabetes Microsimulation Model to Estimate Long ...

This study aimed to develop a microsimulation model to estimate the health effects, costs, and cost-effectiveness of public health and clinical interventions ...

A New Type 2 Diabetes Microsimulation Model to Estimate Long ...

The intervention to reduce hemoglobin A1c increased medical costs by $1256 and QALYs by 0.39, yielding an incremental cost-effectiveness ratio ...

Microsimulation as a flexible tool to evaluate policies and their ...

... assess medical technology cost-effectiveness, such as cohort-based state transition models. It can model policy interactions and effects ...